LRCXLam Research

$318.81+154% 1Y

Is the business good?

Good

A genuinely good business: 8 of 9 health tests passed, margins widening, and elite returns on assets.

3 good, 1 neutral
Fundamental health (F-score)8 / 9SEC EDGAR · Jun 28, 2026

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash0.81×derived · Jun 28, 2026

Operating profit is mostly backed by cash. Conversion is worsening vs a year ago.

Margin direction, 3 years+6.1 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from30% ROA

High-quality, exceptional returns on the assets themselves, not leverage. ROE 60% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbehind 77% of the market
Leverage (Debt/EBITDA)top 10% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is LRCX?

Lam Research earns 61% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

61%

Return on invested capital · cost of capital 9.0% · 52 points above what the capital costs: growth creates value

Operating margin
35%

Operating margin · Semiconductor Equipment & Materials median 11% · 12 months to Q4 2026

Cash conversion
0.81×

Cash conversion · 1.16× a year ago · most of the operating profit arrived as cash, working capital took the rest

R&D as % of revenue
10%

R&D as % of revenue

Operating margin by fiscal year
YearOperating margin
FY202131%
FY202231%
FY202330%
FY202429%
FY202532%
FY202635%
Details›
Gross margin12 months to Q4 2026
50%
Operating margin12 months to Q4 2026
35%
Net margin12 months to Q4 2026
31%
Free cash flow margin
21%
R&D as % of revenue
10%
Revenue, trailing twelve months
$23.2B
Free cash flow, trailing twelve months
$4.89B
Net income, trailing twelve months
$7.27B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
61%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.